Patents-Review.com
ClassID:

20114 ⎘

A61K9/2077 - page 2 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Recent Application in this class:
#301
20200253950
2020-08-13

Pharmaceutical formulations comprising CCR3 antagonists

 #302
20200253933
2020-08-13

METHODS FOR TREATING DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME

 #303
20200237733
2020-07-30

Pharmaceutical preparation

 #304
20200230122
2020-07-23

SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION

 #305
20200222340
2020-07-16

RAPID DISSOLUTION FORMULATION OF A CALCIUM RECEPTOR-ACTIVE COMPOUND

 #306
20200222329
2020-07-16

Abuse deterrent oral solid dosage form

 #307
20200215019
2020-07-09

FERRIC CITRATE DOSAGE FORMS

 #308
20200206305
2020-07-02

Granular Pharmaceutical Composition

 #309
20200197380
2020-06-25

Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof

 #310
20200197370
2020-06-25

NANOPARTICULATE FORMULATION COMPRISING AN mPGES-1 INHIBITOR

 #311
20200197313
2020-06-25

Method for coating pharmaceutical substrates

 #312
20200188378
2020-06-18

Methylphenidate extended release chewable tablet

 #313
20200163926
2020-05-28

Benzonatate modified release solid tablets and capsules

 #314
20200163888
2020-05-28

METHOD FOR TREATING INTESTINAL DISEASES PRESENTING AT LEAST ONE INFLAMMATORY COMPONENT

 #315
20200163886
2020-05-28

Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients

 #316
20200146978
2020-05-14

Taste-masked pharmaceutical compositions

 #317
20200121797
2020-04-23

Modified release formulations containing drug-ion exchange resin complexes

 #318
20200121673
2020-04-23

ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE

 #319
20200121608
2020-04-23

Encased tamper resistant controlled release dosage forms

 #320
20200093809
2020-03-26

SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION

 #321
20200093804
2020-03-26

PHARMACEUTICAL COMPOSITION OF EVEROLIMUS

 #322
20200093786
2020-03-26

SYNERGISTIC USE OF CANNABIS FOR TREATING MULTIPLE MYELOMA

 #323
20200093749
2020-03-26

Abuse deterrent immediate release capsule dosage forms

 #324
20200085750
2020-03-19

FORMULATIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID

 #325
20200085749
2020-03-19

IMMEDIATE-RELEASE TABLETS CONTAINING A DRUG AND PROCESSES FOR FORMING THE TABLETS

 #326
20200069805
2020-03-05

PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE

 #327
20200069693
2020-03-05

DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation

 #328
20200069593
2020-03-05

Immediate release tablet of a benzothiophene compound

 #329
20200069579
2020-03-05

Dispersible compositions

 #330
20200061003
2020-02-27

ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME

 #331
20200054573
2020-02-20

Extended release pharmaceutical composition of clozapine

 #332
20200030448
2020-01-30

COMPOSITIONS COMPRISING FUSIDIC ACID AND PACKAGES THEREFOR

 #333
20200030317
2020-01-30

TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION

 #334
20200009141
2020-01-09

Ceritinib formulation

 #335
20200009082
2020-01-09

ABUSE-PROOFED ORAL DOSAGE FORM

 #336
20200000729
2020-01-02

ERYTHRITOL GRANULES AND METHOD FOR PRODUCING SAME, METHOD FOR PRODUCING TABLETS USING SAME, AND TABLETS

 #337
20190381020
2019-12-19

SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION

 #338
20190380992
2019-12-19

Multiple Sclerosis Treatment Regimen Using Dimethyl Fumarate

 #339
20190358215
2019-11-28

Pharmaceutical composition of apixaban

 #340
20190350868
2019-11-21

Tamper resistant oral opioid agonist formulations

 #341
20190350858
2019-11-21

ORAL TABLET FOR DELIVERY OF ACTIVE INGREDIENTS TO THE GASTROINTESTINAL TRACT

 #342
20190350857
2019-11-21

Oral tablet for taste masking of active ingredients

 #343
20190343833
2019-11-14

Bromocriptine formulations

 #344
20190343787
2019-11-14

Controlled release pharmaceutical compositions comprising a fumaric acid ester

 #345
20190336450
2019-11-07

OSMOTIC DRUG DELIVERY SYSTEM

 #346
20190328674
2019-10-31

ORALLY DISINTEGRATING TABLET

 #347
20190314365
2019-10-17

Oral formulations and lipophilic salts of methylnaltrexone

 #348
20190314283
2019-10-17

Compositions comprising a delivery agent and preparation thereof

 #349
20190290600
2019-09-26

Method for treating depression

 #350
20190290587
2019-09-26

Pulsatile drug delivery system for treating morning akinesia

 #351
20190282578
2019-09-19

NOVEL FORMULATIONS OF A BRUTON'S TYROSINE KINASE INHIBITOR

 #352
20190282507
2019-09-19

Celecoxib and amlodipine formulation and method of making the same

 #353
20190282504
2019-09-19

Stabilized tacrolimus composition

 #354
20190275116
2019-09-12

Shaped mass composition comprising exenatide

 #355
20190275043
2019-09-12

SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR

 #356
20190274959
2019-09-12

Pharmaceutical composition and administrations thereof

 #357
20190269653
2019-09-05

Controlled-release melatonin compositions and related methods

 #358
20190269621
2019-09-05

Tamper-resistant tablet providing immediate drug release

 #359
20190254976
2019-08-22

MEDICAMENT-CONTAINING HOLLOW PARTICLE

 #360
20190240252
2019-08-08

PHARMACEUTICAL COMPOSITIONS

 #361
20190240206
2019-08-08

SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION

 #362
20190231763
2019-08-01

SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION

 #363
20190231699
2019-08-01

Controlled-release solid dosage forms of mesalamine

 #364
20190231698
2019-08-01

Non-extractable oral solid dosage forms

 #365
20190209571
2019-07-11

DPP IV inhibitor formulations

 #366
20190209479
2019-07-11

3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE)

 #367
20190209478
2019-07-11

TABLET FORMULATION FOR CGRP ACTIVE COMPOUNDS

 #368
20190201368
2019-07-04

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #369
20190201347
2019-07-04

Cannabidiol dosage form

 #370
20190201346
2019-07-04

Controlled release and taste masking oral pharmaceutical composition

 #371
20190175508
2019-06-13

Anti-retroviral compositions

 #372
20190151460
2019-05-23

MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES

 #373
20190151300
2019-05-23

Pharmaceutical Formulations Comprising CCR3 Antagonists

 #374
20190142952
2019-05-16

Modified release formulations containing drug-ion exchange resin complexes

 #375
20190142866
2019-05-16

POROUS CARBON PARTICLES FOR USE IN THE TREATMENT OR PREVENTION OF LIVER DISEASE

 #376
20190142771
2019-05-16

Compositions and methods for treating Alzheimer's disease and Parkinson's disease

 #377
20190142767
2019-05-16

ABUSE-PROOFED ORAL DOSAGE FORM

 #378
20190142760
2019-05-16

Particle-based multi-layer therapeutic delivery device and method

 #379
20190134061
2019-05-09

CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITIONS

 #380
20190134015
2019-05-09

SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION

 #381
20190133957
2019-05-09

Modified release tablet composition comprising mirabegron

 #382
20190133926
2019-05-09

Burn Pill Pharmaceutical Smoking Cylinder

 #383
20190125792
2019-05-02

PHARMACEUTICAL COMPOSITIONS COMPRISING FERRIC CITRATE AND METHODS FOR THE PRODUCTION THEREOF

 #384
20190125759
2019-05-02

Orodispersible dosage unit containing an estetrol component

 #385
20190125725
2019-05-02

PHARMACEUTICAL COMPOSITIONS COMPRISING BRIVARACETAM

 #386
20190125700
2019-05-02

ANTIBIOTIC COMPOSITIONS COMPRISING METFORMIN AND METHODS OF USING THE COMPOSITIONS

 #387
20190125674
2019-05-02

Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

 #388
20190117674
2019-04-25

Method of treatment using nanoparticulate ganaxolone formulations

 #389
20190117673
2019-04-25

GANAXOLONE FORMULATION AND USE THEREOF

 #390
20190117646
2019-04-25

Oral formulations and lipophilic salts of methylnaltrexone

 #391
20190117645
2019-04-25

Oral formulations and lipophilic salts of methylnaltrexone

 #392
20190117613
2019-04-25

Controlled release pharmaceutical compositions comprising a fumaric acid ester

 #393
20190117592
2019-04-25

RAPID DISSOLUTION FORMULATION OF A CALCIUM RECEPTOR-ACTIVE COMPOUND

 #394
20190117576
2019-04-25

Sustained release formulations of nalbuphine

 #395
20190111050
2019-04-18

TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION

 #396
20190105314
2019-04-11

Methods and compositions for treating aging-associated impairments using CCR3-inhibitors

 #397
20190105277
2019-04-11

PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF

 #398
20190105275
2019-04-11

Oral pharmaceutical compositions of mesalazine

 #399
20190099417
2019-04-04

ABUSE RESISTANT DRUG FORMULATION

 #400
20190091193
2019-03-28

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #401
20190091192
2019-03-28

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #402
20190091191
2019-03-28

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #403
20190083628
2019-03-21

PHARMACEUTICAL COMPOSITION PARTICLES AND ORALLY DISINTEGRATING PREPARATION INCLUDING THE SAME

 #404
20190083484
2019-03-21

Formulations And Pharmacokinetics Of Deuterated Benzoquinoline Inhibitors Of Vesicular Monoamine Transporter 2

 #405
20190083479
2019-03-21

COMBINATION MEDICATION

 #406
20190083434
2019-03-21

Compositions and methods of using modified release solabegron for lower urinary tract symptoms

 #407
20190083433
2019-03-21

COMPOSITIONS AND METHODS OF USING MODIFIED RELEASE SOLABEGRON FOR LOWER URINARY TRACT SYMPTOMS

 #408
20190076366
2019-03-14

PHARMACEUTICAL COMPOSITION OF ENTECAVIR AND PROCESS OF MANUFACTURING

 #409
20190076363
2019-03-14

Controlled release delivery device comprising an organosol coat

 #410
20190070181
2019-03-07

FORMULATION OF TICAGRELOR OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

 #411
20190070155
2019-03-07

PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL) BENZOIC ACID AND ADMINISTRATION THEREOF

 #412
20190060457
2019-02-28

COMPOSITIONS COMPRISING FUSIDIC ACID AND PACKAGES THEREFOR

 #413
20190060395
2019-02-28

Granular Pharmaceutical Composition

 #414
20190060290
2019-02-28

Method for preparing pharmaceutical composition comprising pyrrolo-fused six-membered heterocyclic compound

 #415
20190060229
2019-02-28

Medical chewing gum comprising cannabinoid

 #416
20190054081
2019-02-21

TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION

 #417
20190054080
2019-02-21

Abuse-resistant pharmaceutical composition for the treatment of opioid dependence

 #418
20190054024
2019-02-21

Solid Dosage Forms

 #419
20190046453
2019-02-14

Controlled release and taste masking oral pharmaceutical composition

 #420
20190030014
2019-01-31

Methylphenidate extended release chewable tablet

 #421
20190029968
2019-01-31

Modified release formulation of lacosamide

 #422
20190022228
2019-01-24

PHARMACEUTICAL FORMULATIONS CONTAINING MICROPARTICLES OR NANOPARTICLES OF A DELIVERY AGENT

 #423
20190022112
2019-01-24

CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITIONS

 #424
20190022095
2019-01-24

CERITINIB FORMULATION

 #425
20190022086
2019-01-24

CONTROLLED RELEASE HYDROCODONE FORMULATIONS

 #426
20190022076
2019-01-24

SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION

 #427
20190022008
2019-01-24

Apixaban solid composition and preparation method thereof

 #428
20190015482
2019-01-17

Pharmaceutical compositions and methods for fabrication of solid masses comprising TNF-inhibiting antibodies

 #429
20190015428
2019-01-17

CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITIONS

 #430
20190015342
2019-01-17

Controlled release and taste masking oral pharmaceutical composition

 #431
20190008926
2019-01-10

Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins

 #432
20190008925
2019-01-10

Pharmaceutical compositions and methods for fabrication of solid masses comprising anti-interleukin antibodies

 #433
20190008777
2019-01-10

Celecoxib and amlodipine formulation and method of making the same

 #434
20190000767
2019-01-03

TAMPER RESISTANT DOSAGE FORMS

 #435
20190000756
2019-01-03

Oral preparation and preparation method thereof

 #436
20180370960
2018-12-27

Solid Oral Formulations and Crystalline Forms of an Inhibitor of Apoptosis Protein

 #437
20180369388
2018-12-27

PHARMACEUTICAL COMPOSITION

 #438
20180369237
2018-12-27

Tamper-resistant dosage form with immediate release and resistance against solvent extraction

 #439
20180369216
2018-12-27

SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION

 #440
20180369149
2018-12-27

Tamper-resistant tablet providing immediate drug release

 #441
20180360918
2018-12-20

Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid

 #442
20180360850
2018-12-20

Thermo-kinetic mixing for pharmaceutical applications

 #443
20180353502
2018-12-13

CONTROLLED RELEASE HYDROCODONE FORMULATIONS

 #444
20180344648
2018-12-06

CLOBAZAM TABLET FORMULATION AND PROCESS FOR ITS PREPARATION

 #445
20180338926
2018-11-29

3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE)

 #446
20180338923
2018-11-29

FORMULATIONS FOR DELIVERING INSULIN

 #447
20180326065
2018-11-15

Methods and compositions for self-regulated release of active pharmaceutical ingredient

 #448
20180326018
2018-11-15

Alkaline phosphatase formulations

 #449
20180325855
2018-11-15

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #450
20180325852
2018-11-15

ALDITOL-FREE, STORAGE-STABLE THYROID HORMONE ACTIVE DRUG FORMULATIONS AND METHODS FOR THEIR PRODUCTION

 #451
20180318225
2018-11-08

Controlled release and taste masking oral pharmaceutical composition

 #452
20180311266
2018-11-01

COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2

 #453
20180311170
2018-11-01

Pharmaceutical composition containing clomipramine and preparation method therefor

 #454
20180303826
2018-10-25

ABUSE RESISTANT DRUG FORMULATION

 #455
20180296586
2018-10-18

USE OF NADPH FOR PREPARATION OF A DRUG FOR ANTIPLATELET AGGREGATION

 #456
20180296501
2018-10-18

Methods of treating developmental encephalopathies

 #457
20180296486
2018-10-18

FOOD INDEPENDENT IMMEDIATE RELEASE DRUG FORMULATION WITH ABUSE DETERRENCE AND OVERDOSE PROTECTION

 #458
20180289716
2018-10-11

DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION

 #459
20180280307
2018-10-04

Solid oral dosage forms of eslicarbazepine

 #460
20180271868
2018-09-27

Pharmaceutical preparation comprising phenylalanine derivative

 #461
20180263980
2018-09-20

Stable pharmaceutical compositions comprising a pyrimidine-sulfamide

 #462
20180263978
2018-09-20

Bromocriptine formulations

 #463
20180263947
2018-09-20

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #464
20180256555
2018-09-13

SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION

 #465
20180250304
2018-09-06

Pharmaceutical compositions of linagliptin and process for preparation thereof

 #466
20180250233
2018-09-06

TABLETS HAVING MEDIA INDEPENDENT ACTIVE SUBSTANCE DELIVERY

 #467
20180250227
2018-09-06

Nanosuspension formulation

 #468
20180243277
2018-08-30

GRANULATE FORMULATION OF 5-METHYL-1-PHENYL-2-(1H)-PYRIDONE AND METHOD OF MAKING THE SAME

 #469
20180243238
2018-08-30

RAPID DISSOLUTION FORMULATION OF A CALCIUM RECEPTOR-ACTIVE COMPOUND

 #470
20180243237
2018-08-30

ABUSE-PROOFED DOSAGE FORM

 #471
20180235966
2018-08-23

Pharmaceutical composition of alogliptin and metformin

 #472
20180235908
2018-08-23

ABUSE-PROOFED ORAL DOSAGE FORM

 #473
20180235888
2018-08-23

Tablet formulation comprising a GLP-1 peptide and a delivery agent

 #474
20180235877
2018-08-23

Taste-masked pharmaceutical compositions

 #475
20180228779
2018-08-16

Modified release compositions comprising tacrolimus

 #476
20180228733
2018-08-16

MEDICAMENT-CONTAINING HOLLOW PARTICLE

 #477
20180228727
2018-08-16

Taste-masked pharmaceutical compositions

 #478
20180221285
2018-08-09

ORAL FORMULATIONS OF DEFERASIROX

 #479
20180214443
2018-08-02

Pharmaceutical preparation containing oxycodone and naloxone

 #480
20180214437
2018-08-02

NEW ALFENTANIL COMPOSITION FOR THE TREATMENT OF ACUTE PAIN

 #481
20180214422
2018-08-02

Solid dispersions comprising tacrolimus

 #482
20180200221
2018-07-19

BENZONATATE MODIFIED RELEASE SOLID TABLETS AND CAPSULES

 #483
20180193319
2018-07-12

Regimen for suppressing organ rejection

 #484
20180185378
2018-07-05

ANTIMICROBIAL DELIVERY SYSTEM FOR THE PREVENTION AND TREATMENT OF INFECTIONS IN THE COLON

 #485
20180185292
2018-07-05

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

 #486
20180185289
2018-07-05

MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION

 #487
20180169022
2018-06-21

Orodispersible dosage unit containing an estetrol component

 #488
20180161280
2018-06-14

PHARMACEUTICAL COMPOSITIONS COMPRISING EVEROLIMUS

 #489
20180153815
2018-06-07

Tamper resistant dosage forms

 #490
20180153814
2018-06-07

Tamper resistant dosage forms

 #491
20180153812
2018-06-07

ALCOHOL RESISTANT DOSAGE FORMS

 #492
20180147152
2018-05-31

RAPID DISSOLVE TABLET COMPOSITIONS FOR VAGINAL ADMINISTRATION

 #493
20180133166
2018-05-17

Modified-release therapeutic systems for oral administration of menthol in the treatment of intestinal disorders

 #494
20180125790
2018-05-10

Sustained Release Aminopyridine Composition

 #495
20180125789
2018-05-10

Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde

 #496
20180125785
2018-05-10

Rivastigmine-containing sustained-release pharmaceutical composition

 #497
20180117009
2018-05-03

3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE)

 #498
20180116966
2018-05-03

Immediate-release tablets containing combimetinib and methods of making and using the same

 #499
20180104249
2018-04-19

PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF

 #500
20180104235
2018-04-19

NEW ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE

 #501
20180099053
2018-04-12

PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE

 #502
20180098982
2018-04-12

ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF

 #503
20180098957
2018-04-12

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #504
20180092868
2018-04-05

Compositions and methods for treating Alzheimer's disease and Parkinson's disease

 #505
20180085316
2018-03-29

Gelated microparticle suitable for oral delivery of therapeutic peptides to the lower intestine

 #506
20180078544
2018-03-22

TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION

 #507
20180078505
2018-03-22

Procedure for preparing enteric-coated pellets containing a proton pump inhibitor and multi-particle pharmaceutical compositions containing them

 #508
20180071292
2018-03-15

Ribociclib tablet

 #509
20180071270
2018-03-15

TABLETED COMPOSITIONS CONTAINING ATAZANAVIR

 #510
20180064715
2018-03-08

Tablet compositions

 #511
20180055845
2018-03-01

Pharmaceutical compositions comprising Akt protein kinase inhibitors

 #512
20180055820
2018-03-01

Composition for the treatment of neuropathies and/or neuropathic pain

 #513
20180055774
2018-03-01

SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION

 #514
20180042920
2018-02-15

NEW ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE

 #515
20180042859
2018-02-15

Tamper resistant oral opioid agonist formulations

 #516
20180042855
2018-02-15

IMMEDIATE RELEASE FORMULATIONS AND DOSAGE FORMS OF GAMMA-HYDROXYBUTYRATE

 #517
20180042852
2018-02-15

Sustained release formulation of nalbuphine

 #518
20180028537
2018-02-01

Formulations of a Bruton's tyrosine kinase inhibitor

 #519
20180028483
2018-02-01

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #520
20180028450
2018-02-01

Encased Tamper Resistant Controlled Release Dosage Forms

 #521
20180008603
2018-01-11

PHARMACEUTICAL COMPOSITION CONTAINING CRYSTALLINE MACITENTAN

 #522
20180008546
2018-01-11

FORMULATIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID

 #523
20180000954
2018-01-04

MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES

 #524
20180000792
2018-01-04

MODIFIED RELEASE COMPOSITIONS OF EPALRESTAT OR A DERIVATIVE THEREOF AND METHODS FOR USING THE SAME

 #525
20170360797
2017-12-21

Method for treating cancer

 #526
20170360754
2017-12-21

ANTICANCER COMPOSITIONS

 #527
20170360734
2017-12-21

Anti-RDS compounds and method of manufacture and administration thereof to induce dopamine homeostatis

 #528
20170354654
2017-12-14

Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent

 #529
20170354607
2017-12-14

TAMPER RESISTANT DOSAGE FORMS

 #530
20170348241
2017-12-07

TAMPER RESISTANT DOSAGE FORMS

 #531
20170348240
2017-12-07

TAMPER RESISTANT DOSAGE FORMS

 #532
20170348239
2017-12-07

SOLID ORAL PHARMACEUTICAL COMPOSITION

 #533
20170348236
2017-12-07

METHOD FOR PRODUCING MICROPARTICLES

 #534
20170340744
2017-11-30

Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant

 #535
20170340632
2017-11-30

Bromocriptine formulations

 #536
20170326139
2017-11-16

COMBINATION THERAPY FOR MALE SEXUAL DYSFUNCTION

 #537
20170326110
2017-11-16

Solid pharmaceutical composition comprising amlodipine and losartan

 #538
20170319498
2017-11-09

TAMPER RESISTANT DOSAGE FORMS

 #539
20170319497
2017-11-09

TAMPER RESISTANT DOSAGE FORMS

 #540
20170319496
2017-11-09

TAMPER RESISTANT DOSAGE FORMS

 #541
20170319495
2017-11-09

TAMPER RESISTANT DOSAGE FORMS

 #542
20170319494
2017-11-09

TAMPER RESISTANT DOSAGE FORMS

 #543
20170319493
2017-11-09

TAMPER RESISTANT DOSAGE FORMS

 #544
20170319492
2017-11-09

TAMPER RESISTANT DOSAGE FORMS

 #545
20170319491
2017-11-09

TAMPER RESISTANT DOSAGE FORMS

 #546
20170319490
2017-11-09

TAMPER RESISTANT DOSAGE FORMS

 #547
20170319489
2017-11-09

TAMPER RESISTANT DOSAGE FORMS

 #548
20170319488
2017-11-09

TAMPER RESISTANT DOSAGE FORMS

 #549
20170312287
2017-11-02

DPP IV INHIBITOR FORMULATIONS

 #550
20170304394
2017-10-26

Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance

 #551
20170304323
2017-10-26

Controlled release and taste masking oral pharmaceutical compositions

 #552
20170304322
2017-10-26

Controlled release and taste masking oral pharmaceutical compositions

 #553
20170304246
2017-10-26

Solid pharmaceutical preparation containing levothyroxine

 #554
20170304209
2017-10-26

Controlled release and taste masking oral pharmaceutical composition

 #555
20170296512
2017-10-19

3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE)

 #556
20170290811
2017-10-12

ORAL FORMULATIONS OF DEFERASIROX

 #557
20170281609
2017-10-05

Granulate formulation of 5-methyl-1-phenyl-2-(1H)-pyridone and method of making the same

 #558
20170274088
2017-09-28

Modified release formulations containing drug-ion exchange resin complexes

 #559
20170258768
2017-09-14

Compositions, methods and kits for treating diarrhea-predominant irritable bowel syndrome

 #560
20170258730
2017-09-14

SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION

 #561
20170246161
2017-08-31

ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE

 #562
20170239354
2017-08-24

Methods and compositions for self-regulated release of active pharmaceutical ingredient

 #563
20170239184
2017-08-24

Particles of spherically agglomerated lactose for direct compression and method of preparation thereof

 #564
20170231993
2017-08-17

Solid pharmaceutical compositions containing an integrase inhibitor

 #565
20170196815
2017-07-13

MEDICAMENT-CONTAINING HOLLOW PARTICLE

 #566
20170157060
2017-06-08

Abuse deterrent immediate release coated reservoir solid dosage form

 #567
20170157052
2017-06-08

IMMEDIATE RELEASE DOSAGE FORMS THAT DETER ABUSE BY ORAL INGESTION OF MULTIPLE DOSAGE UNITS

 #568
20170151229
2017-06-01

Methods of manufacturing oral formulations

 #569
20170143741
2017-05-25

Controlled release and taste masking oral pharmaceutical compositions

 #570
20170143678
2017-05-25

Pharmaceutical composition for oral administration

 #571
20170143670
2017-05-25

Orally disintegrating tablet containing asenapine

 #572
20170136022
2017-05-18

SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR

 #573
20170136006
2017-05-18

Methods of manufacturing oral dosage forms

 #574
20170135991
2017-05-18

NANOPARTICULATE FORMULATION COMPRISING A mPGES-1 INHIBITOR

 #575
20170135989
2017-05-18

ALLISARTAN ISOPROXIL SOLID DISPERSION AND PHARMACEUTICAL COMPOSITION

 #576
20170128419
2017-05-11

Controlled-release melatonin compositions and related methods

 #577
20170119759
2017-05-04

Pharmaceutical formulation of N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-YL]-4-[(3R,5S)-3 ,5-dimethylpiperazin-1-YL] benzamide

 #578
20170119675
2017-05-04

Stabilized tacrolimus composition

 #579
20170119674
2017-05-04

Solid oral dosage form of lipophilic compounds

 #580
20170112834
2017-04-27

CERITINIB FORMULATION

 #581
20170112828
2017-04-27

Pharmaceutical preparation containing oxycodone and naloxone

 #582
20170112799
2017-04-27

Amorphous solid dispersion comprising taxane, tablet comprising the same, and method for preparing the same

 #583
20170112771
2017-04-27

3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE)

 #584
20170112770
2017-04-27

Controlled release delivery device comprising an organosol coat

 #585
20170106018
2017-04-20

Pharmaceutical compositions comprising ferric citrate and methods for the production thereof

 #586
20170100487
2017-04-13

Modified release formulations containing drug-ion exchange resin complexes

 #587
20170100480
2017-04-13

Controlled release formulations of levodopa and uses thereof

 #588
20170100340
2017-04-13

Pharmaceutical composition and administrations thereof

 #589
20170088430
2017-03-30

APPLICATION OF SILICON DIOXIDE AEROGEL AS NANO-DRUG CARRYING SYSTEM IN PHARMACY

 #590
20170087147
2017-03-30

FORMULATIONS PHARMACOKINETICS OF DEUTERATED BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2

 #591
20170081319
2017-03-23

Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein

 #592
20170079922
2017-03-23

Controlled release and taste masking oral pharmaceutical composition

 #593
20170079919
2017-03-23

Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients

 #594
20170071930
2017-03-16

PHARMACEUTICAL COMPOSITIONS OF CETP INHIBITORS

 #595
20170071927
2017-03-16

Alfentanil composition for the treatment of acute pain

 #596
20170065527
2017-03-09

Tamper resistant dosage forms

 #597
20170065521
2017-03-09

BIOPHARMA APPLICATION OF MICELL TECHNOLOGY

 #598
20170056339
2017-03-02

Formulation of fat-soluble vitamin

 #599
20170035745
2017-02-09

Pharmaceutical combinations of dabigatran and proton pump inhibitors

 #600
20170035707
2017-02-09

Oral dosage forms of ketamine